Market Overview

The Global Biopharmaceutical Market was valued at USD 516,979.3 million in 2023 and is expected to reach USD 964,003.7 million by 2031 while growing at a CAGR of 8.1% during the forecast period (2024-2031). 

 *Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Market Dynamics

This section of the report will analyze various driving and restraining factors that are expected to have a significant impact on the global biopharmaceutical Market growth. Biopharmaceuticals, also known as biologics, are pharmaceuticals created from living cells and biological systems, setting them apart from chemically synthesized small-molecule drugs. These large, complex molecules are often derived from living organisms like bacteria, yeast, or mammalian cells, and play a vital role in modern medicine by providing innovative treatments for diverse diseases and medical conditions.

The growing prevalence of chronic diseases like cancer, diabetes, autoimmune disorders, and cardiovascular diseases, along with rising investments in Research and Development (R&D), are expected to drive significant growth in the biopharmaceutical market. However, obstacles such as stringent regulatory requirements, approval processes, and substantial research and development costs may impede market expansion.

Furthermore, the global biopharmaceutical industry will be analyzed through various tools including PESTLE analysis, and Porter’s analysis.

Segmentation – By Product Type Analysis

The Global Biopharmaceutical Market is segmented among Monoclonal Antibodies, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Vaccines, Recombinant Enzymes, Cell and Gene Therapies, Synthetic Immunomodulators, and Other Product Types, based on Product Type. In 2023, Monoclonal Antibodies accounted for the majority of the market share*. 

 *Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Segmentation – By Therapeutic Application Analysis

The Global Biopharmaceutical Market is segmented among Oncology, Inflammatory and Infectious Diseases, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders, Cardiovascular Diseases, Neurological Diseases, and Other Therapeutic Applications, based on therapeutic application. In 2023, Autoimmune Disorders accounted for the majority of the market share*. 

 *Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Global Biopharmaceutical Market: Regional Analysis

Based on region, the market is divided into six regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. In 2023, North America dominated the market with the highest market share, while Asia Pacific is expected to grow with the highest CAGR during the forecast period (2024 – 2031). 

 *Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Competitive Landscape

Some of the key players operating in the market are Abbvie Inc., Amgen Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, Johnson & Johnson, Novartis AG, Novo Nordisk AS, Pfizer Inc., GlaxoSmithKline PLC, and F. Hoffmann-La Roche AG.

Table of Contents:

1. Research Methodology and Market Scope

• Research Methodology

• Market Scope

2. Executive Summary

3. Global Biopharmaceutical Market Dynamics

• Drivers

• Restraints

• Opportunity

4. Global Biopharmaceutical Industry Analysis

• PEST Analysis

• Porter's Five Force Analysis

• Recent Deals Analysis

5. Global Biopharmaceutical Market Segmentation, By Product Type

• Global Biopharmaceutical Market Share Analysis, By Product Type

• Global Biopharmaceutical Market Growth Analysis, By Product Type

• Global Biopharmaceutical Market Trends, By Product Type

o Monoclonal Antibodies

Ø Anti-cancer Monoclonal Antibodies

Ø Anti-inflammatory Monoclonal Antibodies

Ø Other Monoclonal Antibodies

o Recombinant Growth Factors

Ø Erythropoietin

Ø Granulocyte Colony Stimulating Factor

o Purified Proteins

Ø Leukemia Inhibitory Factor (LIF)

Ø P53 Protein

Ø P38 Protein

Ø Other Purified Proteins

o Recombinant Proteins

Ø Serum Albumin

Ø Amyloid Protein

Ø Defensin

Ø Transferrin

o Recombinant Hormones

Ø Recombinant Human Growth Hormones

Ø Recombinant Insulin

Ø Other Recombinant Hormones

o Vaccines

Ø Recombinant Vaccines

§ Cancer Vaccine

§ Malaria Vaccine

§ Ebola Vaccine

§ Hepatitis-B Vaccine

§ Tetanus Vaccine

§ Diptheria Vaccine

§ Cholera Vaccine

§ Other Recombinant Vaccines

Ø Conventional Vaccines

§ Polio Vaccine

§ Pox Vaccine

§ Other Conventional Vaccines

o Recombinant Enzymes

Ø Enterokinase

Ø Cyclase

Ø Caspase

Ø Cathepsin

o Cell and Gene Therapies

Ø Allogenic Products

Ø Autologous Products

Ø Acellular Products

o Synthetic Immunomodulators

Ø Cytokines, Interferons, and Interleukins

o Other Product Types

Ø Blood Factors

Ø Other Product Types

6. Global Biopharmaceutical Market Segmentation, By Therapeutic Application

• Global Biopharmaceutical Market Share Analysis, By Therapeutic Application

• Global Biopharmaceutical Market Growth Analysis, By Therapeutic Application

• Global Biopharmaceutical Market Trends, By Therapeutic Application

o Oncology

o Inflammatory and Infectious Diseases

o Autoimmune Disorders

o Metabolic Disorders

o Hormonal Disorders

o Cardiovascular Diseases

o Neurological Diseases

o Other Therapeutic Applications

7. Global Biopharmaceutical Market Segmentation, By Region

• Global Biopharmaceutical Market Share Analysis, By Region

• Global Biopharmaceutical Market Growth Analysis, By Region

• Global Biopharmaceutical Market Trends, By Region

o North America

o Europe

o Asia Pacific

o Latin America

o Middle East

o Africa

8. Competitive Landscape

• Abbvie Inc.*

o Company Overview

o Financial Performance

o Key Development/Strategies

o SWOT Analysis

• Amgen Inc.

• Bristol-Myers Squibb Company

• Eli Lilly and Company

• Johnson & Johnson

• Novartis AG

• Novo Nordisk AS

• Pfizer Inc.

• GlaxoSmithKline PLC

• F. Hoffmann-La Roche AG

*Similar analysis will be provided for each company listed above.